Sara Eapen, Ph.D.
Dr. Sara Eapen is a biostatistician with over 15 years of experience in collaborative clinical research and statistical consulting in academia and industry. She started her career working on phase II and III clinical trials in Dana-Farber Cancer Institute before moving on to phase I trials at Novartis. She switched to health economic and outcomes research when she joined Analysis Group in 2008. While there, Sara worked on pharmacoeconomics evaluations and outcome studies, study design and data analysis to support product marketing, reimbursement strategies, health care policy and regulation, large database retrospective analyses, clinical trial analyses, and meta-analyses. Prior to joining Aetion, Sara worked at Flatiron Health where she managed the quantitative science team and supported product development. Sara holds a doctorate degree in Biostatistics from University of Rochester. She lives in Cambridge, MA with her partner, Maarten and dog, Cato. When not watching crime shows or working out, Sara is an avid cook and believes in connecting with people through food.